US cell therapy manufacturing company Cellares has secured a $20 million investment from Cathie Wood’s ARK Invest, raising ...

Shares in US biotech Tango Therapeutics closed 53% higher on Monday after the company reported early data for its PRMT5 ...

US biotech City Therapeutics has raised $99.5 million in a series B financing, giving the young RNA interference specialist ...

USA-based private clinical stage biopharma AmMax Bio and Switzerland’s Lonza, a leading contract development and manufacturing organization (CDMO), today announced a non-exclusive licensing agreement.

US life sciences tools company Standard BioTools (Nasdaq: LAB) has agreed to merge with privately-held Treeline Biosciences in an all-stock deal that will turn the business into a clinical-stage ...

US pharma majors Merck & Co and Gilead Sciences today announced the discontinuation of the Phase III KEYNOTE-D46/EVOKE-03 ...

Scottish biotech company Bead BioPharma has emerged from stealth after filing its first patent application for a ...

UK biotech Engitix, which is pioneering extracellular matrix (ECM)-driven drug discovery, today announced a strategic ...

Swiss pharma giant Roche has entered into an exclusive licensing and collaboration agreement with Nurix Therapeutics.

US biopharma company MannKind Corporation has presented new clinical and real-world data on Afrezza (insulin human) at the ...

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has called for stronger action on rare diseases ...

Russian pharmaceutical company KhimRar Group is expanding its capacities for the production of active pharmaceutical ...